1 of 1
Story summary
- Procter & Gamble Co. announced on August 4, 2026 that it will acquire supplement maker Thorne Healthtech for $3.8 billion.
- Thorne, founded in 1984, went public in 2021 at a $525 million valuation and was taken private in 2023 for $680 million.
- P&G said the deal expands its prevention range.
- Its shares rose about 1 % even as the company forecast slower overall sales growth.
